Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF814 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | ZBTB18 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | GOLGA8M | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | HMGN2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | NEUROG3 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | GRAMD4 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | CAMKV | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
mRNA | CEP68 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | NRXN2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | GOLGA8J | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |